SBIR-STTR Award

Tas::75 0893::Tas Rapid Quantitative Point Of Care Test For Nicotine Metabolite
Award last edited on: 2/4/14

Sponsored Program
SBIR
Awarding Agency
NIH
Total Award Amount
$150,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Aniruddha P Puntambekar

Company Information

Siloam Biosciences Inc

413 Northland Boulevard
Cincinnati, OH 45240
   (513) 429-2976
   N/A
   www.siloambio.com
Location: Single
Congr. District: 01
County: Hamilton

Phase I

Contract Number: 271201000010C-0-0-1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2010
Phase I Amount
$150,000
The goal of this fast-track SBIR project is to develop the first ever, point-if-care test (POCT) to determine the ratio of nicotine metabolites; 3-hydroxycotinine/cotinine (3HC/COT). This test can be used by physicians to adapt nicotine replacement therapies/non-nicotine drugs for smoking cessation programs.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----